Showing results (61-70 of 81) with videos related to
Sort By:
Pageof 9
Haematologica|November 13, 2025
A scoring system to predict life-threatening thromboischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG studyRebeca Rodríguez-Veiga, Cristina Gil, Marta Sobas, et al.Transplantation and Cellular Therapy|February 16, 2025
Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry ExperienceJosefina Serrano, David Martínez-Cuadrón, Cristina Gil, et al.Cancer|April 10, 2026
Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registryJuan M Alonso-Dominguez, Tamara Castaño-Bonilla, Cristina Gil, et al.Transplantation and Cellular Therapy|April 10, 2021
Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA StudyEduardo Rodríguez-Arbolí, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, et al.Clinical Lymphoma, Myeloma & Leukemia|January 29, 2014
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry: a bridge to individualized medicineTeresa A Bennett, Pau Montesinos, Federico Moscardo, et al.Bone Marrow Transplantation|May 7, 2026
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA groupRafael Colmenares, Eva Barragán, Rebeca Rodríguez-Veiga, et al.Leukemia Research|December 24, 2025
Interlaboratory cross validation of acute myeloid leukemia fusion genes and mutational targets detected by PCR: Performance of PETHEMA central laboratoriesMargarida Coucelo, Claudia Sargas, Rosa Ayala, et al.Cancers|June 10, 2022
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid LeukemiaDavid Martínez-Cuadrón, Josefina Serrano, José Mariz, et al.Haematologica|November 12, 2020
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML projectClaudia Sargas, Rosa Ayala, María Carmen Chillón, et al.Cancer|January 3, 2025
Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry studyPilar Lloret-Madrid, Blanca Boluda, Joaquín Martínez-López, et al.Pageof 9